Skip to main content
logo
Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
30.43
-0.24 (-0.78%)
Nov 3, 2026, 12:51 PM EST - Market open

Pfizer Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Revenue
16,58315,03414,45117,55716,65414,65313,71517,76317,70213,28314,87814,56913,49213,00718,48524,29022,63827,74225,66123,838
Revenue Growth
-0.43%2.60%5.37%-1.16%-5.92%10.31%-7.82%21.92%31.20%2.12%-19.51%-40.02%-40.40%-53.11%-27.96%1.90%-5.81%46.79%76.78%108.61%
Gross Profit
12,55511,37911,04412,49212,67511,15211,12311,25012,82910,51511,84213,5034,5879,93513,73814,81516,60119,11715,70314,127
Operating Income
5,1324,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,745
Net Income
3,242-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,393
Earnings Per Share
0.56-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.970.871.511.741.370.59
EPS Growth
-9.68%--10.05%--21.31%6973.98%-5.30%---98.23%-43.40%---76.40%-29.10%47.11%5.50%77.42%59.09%289.72%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Primary Care
6,9715,5035,5427,9387,6425,5355,6928,9119,0604,9527,2117,0446,3105,88411,56017,34815,84620,97918,85116,225
Oncology
4,3274,1653,826-3,9384,0343,494-------------
Specialty Care
3,3493,3532,939-3,1303,0892,616-------------
Hospital and Biosimilars
1,6351,6401,854-1,6001,6471,639-------------
Business Innovation (Pfizer CentreOne)
300373289409344348273325285278258364293307308368319317338382
Revenue (Total)
16,58315,03414,45117,55716,65414,65313,71517,76317,70213,28314,87914,56913,49113,00718,48625,13522,63827,74225,66123,838

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Cash & Investments
11,70411,70413,08113,59614,98613,24917,31920,4779,9537,10011,92912,69044,18244,78519,97222,73236,13233,31223,90231,073
Total Debt
63,48063,48064,73167,64761,93862,04462,39767,41867,94569,85869,90275,33264,13365,67436,16639,37736,99940,49036,44141,395
Net Cash (Debt)
-51,776-51,776-51,650-54,051-46,952-48,795-45,078-46,941-57,992-62,758-57,973-62,642-19,951-20,889-16,194-16,645-867-7,178-12,539-10,322
Net Cash Growth
--------------------
Net Cash Per Share
-9.00-9.09-9.01-9.51-8.22-8.55-7.89-8.23-10.17-11.02-10.18-11.09-3.53-3.66-2.83-2.90-0.15-1.26-2.18-1.79

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Cash Flow
-8352,6155,3484,603-2,3356,7216,714-1,7811,0905,2403,456-1,2081,2128,5825,9748,1706,5415,914
Capital Expenditures
--533-436-845-602--564-917-651-637-704-1,044-810-914-1,139-1,001-841-751-643-1,002
Free Cash Flow
-3022,1794,5034,001-1,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,912
Free Cash Flow Growth
--23.04%-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%2.08%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Gross Margin
75.71%75.69%76.42%71.15%76.11%76.11%81.10%63.33%72.47%79.16%79.59%92.68%34.00%76.38%74.32%60.99%73.33%68.91%61.19%59.26%
Operating Margin
30.95%27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.69%21.44%37.14%25.59%44.83%44.29%40.33%28.29%
Pretax Margin
20.42%-4.34%21.93%-9.35%20.02%20.77%20.30%-0.06%26.64%-0.78%22.99%-28.34%-24.84%17.44%33.92%21.53%39.76%41.27%35.27%16.05%
Profit Margin
19.55%-1.65%18.59%-9.39%21.26%19.86%21.63%2.31%25.22%0.31%20.94%-23.12%-17.66%17.89%29.99%20.56%38.02%35.71%30.65%14.23%
FCF Margin
-2.01%15.08%25.65%24.02%-12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.40%31.21%22.67%26.74%22.98%20.61%

Dividends
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Dividend Per Share
-0.4300.4300.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.390
Dividend Per Share Growth
-0%0%2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%
Dividend Yield
-8.85%7.97%8.63%8.96%8.76%8.39%7.92%5.74%5.93%5.95%5.70%4.91%4.42%3.95%3.12%3.63%3.01%3.03%2.65%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
PE Ratio
40.52-20.54-13.7512.7918.1418.7238.77----9.647.939.178.2510.0111.6215.08
Forward PE
10.358.549.138.548.468.598.559.9111.1812.2812.5419.2510.9411.4911.9510.827.657.787.1710.64
P/FCF Ratio
-12.6014.4013.7811.67-12.7415.2920.04-30.7833.9222.90-11.4011.0510.5110.329.1211.10
PS Ratio
2.572.172.432.262.152.152.292.362.732.822.812.732.702.642.472.872.462.903.144.08